AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 20 filers reported holding AKARI THERAPEUTICS PLC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 426,297 | $2,617,000 | 0.72% |
| Vivo Capital, LLC | 345,850 | $2,124,000 | 0.43% |
| Hikari Power Ltd | 151,334 | $929,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 433,551 | $2,662,000 | 0.12% |
| NEA Management Company, LLC | 452,167 | $2,776,000 | 0.10% |
| Baker Brothers Advisors | 496,901 | $3,051,000 | 0.02% |
| HUNTINGTON NATIONAL BANK | 8,000 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 115,543 | $709,000 | 0.00% |
| DEUTSCHE BANK AG\ | 5,300 | $32,000 | 0.00% |
| MORGAN STANLEY | 8,807 | $54,000 | 0.00% |